ID TF_HUMAN Reviewed; 295 AA. AC P13726; D3DT47; Q6FHG2; Q86WH4; DT 01-JAN-1990, integrated into UniProtKB/Swiss-Prot. DT 01-JAN-1990, sequence version 1. DT 27-MAR-2024, entry version 233. DE RecName: Full=Tissue factor; DE Short=TF; DE AltName: Full=Coagulation factor III; DE AltName: Full=Thromboplastin; DE AltName: CD_antigen=CD142; DE Flags: Precursor; GN Name=F3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RX PubMed=2823875; DOI=10.1021/bi00391a004; RA Scarpati E.M., Wen D., Broze G.J. Jr., Miletich J.P., Flandermeyer R.R., RA Siegel N.R., Sadler J.E.; RT "Human tissue factor: cDNA sequence and chromosome localization of the RT gene."; RL Biochemistry 26:5234-5238(1987). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RX PubMed=3297348; DOI=10.1016/0092-8674(87)90669-6; RA Morrissey J.H., Fakhrai H., Edgington T.S.; RT "Molecular cloning of the cDNA for tissue factor, the cellular receptor for RT the initiation of the coagulation protease cascade."; RL Cell 50:129-135(1987). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RX PubMed=3037536; DOI=10.1073/pnas.84.15.5148; RA Spicer E.K., Horton R., Bloem L., Bach R., Williams K.R., Guha A., RA Kraus J., Lin T.C., Nemerson Y., Konigsberg W.H.; RT "Isolation of cDNA clones coding for human tissue factor: primary structure RT of the protein and cDNA."; RL Proc. Natl. Acad. Sci. U.S.A. 84:5148-5152(1987). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RX PubMed=3424286; DOI=10.1016/0049-3848(87)90349-5; RA Fisher K.L., Gorman C.M., Vehar G.A., O'Brien D.P., Lawn R.M.; RT "Cloning and expression of human tissue factor cDNA."; RL Thromb. Res. 48:89-99(1987). RN [5] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=2719931; DOI=10.1021/bi00430a050; RA Mackman N., Morrissey J.H., Fowler B., Edgington T.S.; RT "Complete sequence of the human tissue factor gene, a highly regulated RT cellular receptor that initiates the coagulation protease cascade."; RL Biochemistry 28:1755-1762(1989). RN [6] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBCELLULAR LOCATION, AND RP TISSUE SPECIFICITY. RX PubMed=12652293; DOI=10.1038/nm841; RA Bogdanov V.Y., Balasubramanian V., Hathcock J., Vele O., Lieb M., RA Nemerson Y.; RT "Alternatively spliced human tissue factor: a circulating, soluble, RT thrombogenic protein."; RL Nat. Med. 9:458-462(2003). RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RA Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., RA Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., RA Phelan M., Farmer A.; RT "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."; RL Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases. RN [8] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.; RT "Cloning of human full open reading frames in Gateway(TM) system entry RT vector (pDONR201)."; RL Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases. RN [9] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ALA-36 AND VAL-145. RG SeattleSNPs variation discovery resource; RL Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases. RN [10] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). RN [11] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [12] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Prostate; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [13] RP DISULFIDE BONDS, AND PALMITOYLATION AT CYS-277. RX PubMed=3166978; DOI=10.1021/bi00412a004; RA Bach R., Konigsberg W.H., Nemerson Y.; RT "Human tissue factor contains thioester-linked palmitate and stearate on RT the cytoplasmic half-cystine."; RL Biochemistry 27:4227-4231(1988). RN [14] RP ALTERNATIVE SPLICING, AND INDUCTION. RX PubMed=19168442; DOI=10.1161/circresaha.108.183905; RA Eisenreich A., Bogdanov V.Y., Zakrzewicz A., Pries A., Antoniak S., RA Poller W., Schultheiss H.P., Rauch U.; RT "Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of RT tissue factor in human endothelial cells."; RL Circ. Res. 104:589-599(2009). RN [15] RP INTERACTION WITH HPSE. RX PubMed=20634491; DOI=10.3324/haematol.2010.023713; RA Nadir Y., Brenner B., Fux L., Shafat I., Attias J., Vlodavsky I.; RT "Heparanase enhances the generation of activated factor X in the presence RT of tissue factor and activated factor VII."; RL Haematologica 95:1927-1934(2010). RN [16] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [17] RP X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 33-243. RX PubMed=8086403; DOI=10.1021/bi00202a003; RA Muller Y.A., Ultsch M.H., Kelley R.F., de Vos A.M.; RT "Structure of the extracellular domain of human tissue factor: location of RT the factor VIIa binding site."; RL Biochemistry 33:10864-10870(1994). RN [18] RP X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 33-243. RX PubMed=8609606; DOI=10.1006/jmbi.1996.0073; RA Muller Y.A., Ultsch M.H., de Vos A.M.; RT "The crystal structure of the extracellular domain of human tissue factor RT refined to 1.7-A resolution."; RL J. Mol. Biol. 256:144-159(1996). RN [19] RP X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 33-251 IN COMPLEX WITH FVIIA. RX PubMed=8598903; DOI=10.1038/380041a0; RA Banner D.W., D'Arcy A., Chene C., Winkler F.K., Guha A., Konigsberg W.H., RA Nemreson Y., Kirchhofer D.; RT "The crystal structure of the complex of blood coagulation factor VIIa with RT soluble tissue factor."; RL Nature 380:41-46(1996). RN [20] RP X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 37-242 IN COMPLEX WITH FVIIA. RX PubMed=9925787; DOI=10.1006/jmbi.1998.2452; RA Zhang E., St Charles R., Tulinsky A.; RT "Structure of extracellular tissue factor complexed with factor VIIa RT inhibited with a BPTI mutant."; RL J. Mol. Biol. 285:2089-2104(1999). CC -!- FUNCTION: Initiates blood coagulation by forming a complex with CC circulating factor VII or VIIa. The [TF:VIIa] complex activates factors CC IX or X by specific limited proteolysis. TF plays a role in normal CC hemostasis by initiating the cell-surface assembly and propagation of CC the coagulation protease cascade. {ECO:0000269|PubMed:12652293}. CC -!- SUBUNIT: Interacts with HSPE; the interaction, inhibited by heparin, CC promotes the generation of activated factor X and activates coagulation CC in the presence of activated factor VII. {ECO:0000269|PubMed:20634491, CC ECO:0000269|PubMed:8598903, ECO:0000269|PubMed:9925787}. CC -!- INTERACTION: CC P13726; P55085: F2RL1; NbExp=2; IntAct=EBI-1040727, EBI-4303189; CC P13726; P08709: F7; NbExp=7; IntAct=EBI-1040727, EBI-355972; CC P13726; Q9UM19: HPCAL4; NbExp=3; IntAct=EBI-1040727, EBI-744820; CC -!- SUBCELLULAR LOCATION: [Isoform 1]: Membrane CC {ECO:0000269|PubMed:12652293}; Single-pass type I membrane protein CC {ECO:0000269|PubMed:12652293}. CC -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted CC {ECO:0000269|PubMed:12652293}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Comment=Additional isoforms may exist.; CC Name=1; Synonyms=flTF; CC IsoId=P13726-1; Sequence=Displayed; CC Name=2; Synonyms=asHTF; CC IsoId=P13726-2; Sequence=VSP_041896, VSP_041897; CC -!- TISSUE SPECIFICITY: Lung, placenta and pancreas. CC {ECO:0000269|PubMed:12652293}. CC -!- INDUCTION: TF expression is highly dependent upon cell type. TF can CC also be induced by the inflammatory mediators interleukin 1 and TNF- CC alpha, as well as by endotoxin, to appear on monocytes and vascular CC endothelial cells as a component of cellular immune response. CC {ECO:0000269|PubMed:19168442}. CC -!- SIMILARITY: Belongs to the tissue factor family. {ECO:0000305}. CC -!- WEB RESOURCE: Name=SeattleSNPs; CC URL="http://pga.gs.washington.edu/data/f3/"; CC -!- WEB RESOURCE: Name=Wikipedia; Note=Tissue factor entry; CC URL="https://en.wikipedia.org/wiki/Tissue_factor"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M16553; AAA61151.1; -; mRNA. DR EMBL; J02931; AAA61150.1; -; mRNA. DR EMBL; M27436; AAA36734.1; -; mRNA. DR EMBL; J02846; AAA61152.1; -; Genomic_DNA. DR EMBL; BT019808; AAV38611.1; -; mRNA. DR EMBL; CR541792; CAG46591.1; -; mRNA. DR EMBL; AF487337; AAO61150.1; -; mRNA. DR EMBL; AF540377; AAN01236.1; -; Genomic_DNA. DR EMBL; AC093117; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471097; EAW73044.1; -; Genomic_DNA. DR EMBL; CH471097; EAW73045.1; -; Genomic_DNA. DR EMBL; BC011029; AAH11029.1; -; mRNA. DR CCDS; CCDS53345.1; -. [P13726-2] DR CCDS; CCDS750.1; -. [P13726-1] DR PIR; A43645; KFHU3. DR RefSeq; NP_001171567.1; NM_001178096.1. [P13726-2] DR RefSeq; NP_001984.1; NM_001993.4. [P13726-1] DR PDB; 1AHW; X-ray; 3.00 A; C/F=33-251. DR PDB; 1BOY; X-ray; 2.20 A; A=33-251. DR PDB; 1DAN; X-ray; 2.00 A; T=37-116, U=122-242. DR PDB; 1FAK; X-ray; 2.10 A; T=37-242. DR PDB; 1J9C; X-ray; 2.90 A; T=33-242. DR PDB; 1JPS; X-ray; 1.85 A; T=33-251. DR PDB; 1O5D; X-ray; 2.05 A; T=34-251. DR PDB; 1TFH; X-ray; 2.40 A; A/B=33-251. DR PDB; 1UJ3; X-ray; 2.10 A; C=38-242. DR PDB; 1W0Y; X-ray; 2.50 A; T=33-242. DR PDB; 1W2K; X-ray; 3.00 A; T=33-242. DR PDB; 1WQV; X-ray; 2.50 A; T=33-250. DR PDB; 1WSS; X-ray; 2.60 A; T=33-250. DR PDB; 1WTG; X-ray; 2.20 A; T=33-250. DR PDB; 1WUN; X-ray; 2.40 A; T=33-250. DR PDB; 1WV7; X-ray; 2.70 A; T=33-250. DR PDB; 1Z6J; X-ray; 2.00 A; T=33-243. DR PDB; 2A2Q; X-ray; 1.80 A; T=38-242. DR PDB; 2AEI; X-ray; 2.52 A; T=33-243. DR PDB; 2AER; X-ray; 1.87 A; T=38-242. DR PDB; 2B7D; X-ray; 2.24 A; T=34-251. DR PDB; 2B8O; X-ray; 2.80 A; T=38-242. DR PDB; 2C4F; X-ray; 1.72 A; T=38-112, U=123-242. DR PDB; 2CEF; NMR; -; A=277-295. DR PDB; 2CEH; NMR; -; A=277-295. DR PDB; 2CEZ; NMR; -; A=277-295. DR PDB; 2CFJ; NMR; -; A=277-295. DR PDB; 2EC9; X-ray; 2.00 A; T=38-112, U=123-242. DR PDB; 2F9B; X-ray; 2.54 A; T=34-251. DR PDB; 2FIR; X-ray; 2.00 A; T=38-242. DR PDB; 2FLB; X-ray; 1.95 A; T=34-251. DR PDB; 2FLR; X-ray; 2.35 A; T=34-251. DR PDB; 2HFT; X-ray; 1.69 A; A=33-243. DR PDB; 2PUQ; X-ray; 2.05 A; T=38-241. DR PDB; 2ZP0; X-ray; 2.70 A; T=33-250. DR PDB; 2ZWL; X-ray; 2.20 A; T=33-250. DR PDB; 2ZZU; X-ray; 2.50 A; T=33-250. DR PDB; 3ELA; X-ray; 2.20 A; T=33-241. DR PDB; 3TH2; X-ray; 1.72 A; T=38-242. DR PDB; 3TH3; X-ray; 2.70 A; T=38-242. DR PDB; 3TH4; X-ray; 1.80 A; T=38-242. DR PDB; 4IBL; X-ray; 1.80 A; T=33-251. DR PDB; 4M7L; X-ray; 3.40 A; T=37-245. DR PDB; 4YLQ; X-ray; 1.40 A; T=33-251. DR PDB; 4Z6A; X-ray; 2.25 A; T=36-242. DR PDB; 4ZMA; X-ray; 2.30 A; T=33-251. DR PDB; 5W06; X-ray; 2.60 A; T=37-245. DR PDB; 6R2W; X-ray; 1.25 A; T=33-242. DR PDB; 6Z9W; X-ray; 2.70 A; C/F=21-29. DR PDBsum; 1AHW; -. DR PDBsum; 1BOY; -. DR PDBsum; 1DAN; -. DR PDBsum; 1FAK; -. DR PDBsum; 1J9C; -. DR PDBsum; 1JPS; -. DR PDBsum; 1O5D; -. DR PDBsum; 1TFH; -. DR PDBsum; 1UJ3; -. DR PDBsum; 1W0Y; -. DR PDBsum; 1W2K; -. DR PDBsum; 1WQV; -. DR PDBsum; 1WSS; -. DR PDBsum; 1WTG; -. DR PDBsum; 1WUN; -. DR PDBsum; 1WV7; -. DR PDBsum; 1Z6J; -. DR PDBsum; 2A2Q; -. DR PDBsum; 2AEI; -. DR PDBsum; 2AER; -. DR PDBsum; 2B7D; -. DR PDBsum; 2B8O; -. DR PDBsum; 2C4F; -. DR PDBsum; 2CEF; -. DR PDBsum; 2CEH; -. DR PDBsum; 2CEZ; -. DR PDBsum; 2CFJ; -. DR PDBsum; 2EC9; -. DR PDBsum; 2F9B; -. DR PDBsum; 2FIR; -. DR PDBsum; 2FLB; -. DR PDBsum; 2FLR; -. DR PDBsum; 2HFT; -. DR PDBsum; 2PUQ; -. DR PDBsum; 2ZP0; -. DR PDBsum; 2ZWL; -. DR PDBsum; 2ZZU; -. DR PDBsum; 3ELA; -. DR PDBsum; 3TH2; -. DR PDBsum; 3TH3; -. DR PDBsum; 3TH4; -. DR PDBsum; 4IBL; -. DR PDBsum; 4M7L; -. DR PDBsum; 4YLQ; -. DR PDBsum; 4Z6A; -. DR PDBsum; 4ZMA; -. DR PDBsum; 5W06; -. DR PDBsum; 6R2W; -. DR PDBsum; 6Z9W; -. DR AlphaFoldDB; P13726; -. DR BMRB; P13726; -. DR SMR; P13726; -. DR BioGRID; 108451; 33. DR ComplexPortal; CPX-2808; Coagulation factor VIIa - tissue factor complex. DR CORUM; P13726; -. DR DIP; DIP-6136N; -. DR IntAct; P13726; 7. DR STRING; 9606.ENSP00000334145; -. DR BindingDB; P13726; -. DR ChEMBL; CHEMBL4081; -. DR DrugBank; DB07207; 2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE. DR DrugBank; DB07247; [2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA. DR DrugBank; DB08232; [5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid. DR DrugBank; DB13150; Coagulation factor VII human. DR DrugBank; DB00036; Coagulation factor VIIa Recombinant Human. DR DrugBank; DB06552; rNAPc2. DR DrugBank; DB16732; Tisotumab vedotin. DR DrugCentral; P13726; -. DR TCDB; 8.A.132.2.1; the interferon/interleukin receptor (iir) family. DR GlyConnect; 1811; 1 N-Linked glycan (1 site). DR GlyCosmos; P13726; 2 sites, 1 glycan. DR GlyGen; P13726; 2 sites, 1 N-linked glycan (1 site). DR iPTMnet; P13726; -. DR PhosphoSitePlus; P13726; -. DR SwissPalm; P13726; -. DR BioMuta; F3; -. DR DMDM; 135666; -. DR CPTAC; CPTAC-1479; -. DR EPD; P13726; -. DR jPOST; P13726; -. DR MassIVE; P13726; -. DR MaxQB; P13726; -. DR PaxDb; 9606-ENSP00000334145; -. DR PeptideAtlas; P13726; -. DR ProteomicsDB; 52976; -. [P13726-1] DR ProteomicsDB; 52977; -. [P13726-2] DR Pumba; P13726; -. DR ABCD; P13726; 10 sequenced antibodies. DR Antibodypedia; 4000; 1131 antibodies from 45 providers. DR DNASU; 2152; -. DR Ensembl; ENST00000334047.12; ENSP00000334145.7; ENSG00000117525.14. [P13726-1] DR Ensembl; ENST00000370207.4; ENSP00000359226.4; ENSG00000117525.14. [P13726-2] DR GeneID; 2152; -. DR KEGG; hsa:2152; -. DR MANE-Select; ENST00000334047.12; ENSP00000334145.7; NM_001993.5; NP_001984.1. DR UCSC; uc001dqr.4; human. [P13726-1] DR AGR; HGNC:3541; -. DR CTD; 2152; -. DR DisGeNET; 2152; -. DR GeneCards; F3; -. DR HGNC; HGNC:3541; F3. DR HPA; ENSG00000117525; Low tissue specificity. DR MIM; 134390; gene. DR neXtProt; NX_P13726; -. DR OpenTargets; ENSG00000117525; -. DR PharmGKB; PA158; -. DR VEuPathDB; HostDB:ENSG00000117525; -. DR eggNOG; ENOG502RA1F; Eukaryota. DR GeneTree; ENSGT00390000012668; -. DR HOGENOM; CLU_082139_0_0_1; -. DR InParanoid; P13726; -. DR OMA; PINYVYT; -. DR OrthoDB; 5321079at2759; -. DR PhylomeDB; P13726; -. DR TreeFam; TF352627; -. DR BioCyc; MetaCyc:ENSG00000117525-MONOMER; -. DR PathwayCommons; P13726; -. DR Reactome; R-HSA-140834; Extrinsic Pathway of Fibrin Clot Formation. DR Reactome; R-HSA-9031628; NGF-stimulated transcription. DR SignaLink; P13726; -. DR SIGNOR; P13726; -. DR BioGRID-ORCS; 2152; 9 hits in 1149 CRISPR screens. DR ChiTaRS; F3; human. DR EvolutionaryTrace; P13726; -. DR GeneWiki; Tissue_factor; -. DR GenomeRNAi; 2152; -. DR Pharos; P13726; Tclin. DR PRO; PR:P13726; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; P13726; Protein. DR Bgee; ENSG00000117525; Expressed in mucosa of paranasal sinus and 207 other cell types or tissues. DR GO; GO:0009986; C:cell surface; IDA:BHF-UCL. DR GO; GO:0062023; C:collagen-containing extracellular matrix; IDA:BHF-UCL. DR GO; GO:0009897; C:external side of plasma membrane; IC:BHF-UCL. DR GO; GO:0005615; C:extracellular space; IDA:BHF-UCL. DR GO; GO:0016020; C:membrane; TAS:ProtInc. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:1905286; C:serine-type peptidase complex; IPI:BHF-UCL. DR GO; GO:0004896; F:cytokine receptor activity; IBA:GO_Central. DR GO; GO:0005543; F:phospholipid binding; IDA:BHF-UCL. DR GO; GO:0002020; F:protease binding; IPI:BHF-UCL. DR GO; GO:0002543; P:activation of blood coagulation via clotting cascade; IC:BHF-UCL. DR GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL. DR GO; GO:0002541; P:activation of plasma proteins involved in acute inflammatory response; IDA:BHF-UCL. DR GO; GO:0007596; P:blood coagulation; IDA:BHF-UCL. DR GO; GO:0019221; P:cytokine-mediated signaling pathway; IBA:GO_Central. DR GO; GO:0045766; P:positive regulation of angiogenesis; IDA:BHF-UCL. DR GO; GO:0030335; P:positive regulation of cell migration; TAS:BHF-UCL. DR GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:BHF-UCL. DR GO; GO:0010628; P:positive regulation of gene expression; IMP:ARUK-UCL. DR GO; GO:0032757; P:positive regulation of interleukin-8 production; IMP:ARUK-UCL. DR GO; GO:0010641; P:positive regulation of platelet-derived growth factor receptor signaling pathway; IDA:BHF-UCL. DR GO; GO:0050927; P:positive regulation of positive chemotaxis; IC:BHF-UCL. DR GO; GO:0032008; P:positive regulation of TOR signaling; IMP:BHF-UCL. DR GO; GO:0016485; P:protein processing; IDA:BHF-UCL. DR Gene3D; 2.60.40.10; Immunoglobulins; 2. DR InterPro; IPR003961; FN3_dom. DR InterPro; IPR036116; FN3_sf. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR015373; Interferon/interleukin_rcp_dom. DR InterPro; IPR001187; Tissue_factor. DR InterPro; IPR030472; Tissue_Factor_CS. DR PANTHER; PTHR20859; INTERFERON/INTERLEUKIN RECEPTOR; 1. DR PANTHER; PTHR20859:SF22; TISSUE FACTOR; 1. DR Pfam; PF09294; Interfer-bind; 1. DR Pfam; PF01108; Tissue_fac; 1. DR PIRSF; PIRSF002498; Tissue_factor_3; 1. DR PRINTS; PR00346; TISSUEFACTOR. DR SUPFAM; SSF49265; Fibronectin type III; 2. DR PROSITE; PS00621; TISSUE_FACTOR; 1. DR Genevisible; P13726; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Blood coagulation; Disulfide bond; KW Glycoprotein; Hemostasis; Lipoprotein; Membrane; Palmitate; KW Reference proteome; Secreted; Signal; Transmembrane; Transmembrane helix. FT SIGNAL 1..32 FT CHAIN 33..295 FT /note="Tissue factor" FT /id="PRO_0000033638" FT TOPO_DOM 33..251 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 252..274 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 275..295 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT MOTIF 46..48 FT /note="WKS motif" FT MOTIF 77..79 FT /note="WKS motif" FT MOTIF 190..192 FT /note="WKS motif" FT LIPID 277 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000269|PubMed:3166978" FT CARBOHYD 156 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 169 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 81..89 FT /evidence="ECO:0000269|PubMed:3166978" FT DISULFID 218..241 FT /evidence="ECO:0000269|PubMed:3166978" FT VAR_SEQ 199..238 FT /note="TAKTNTNEFLIDVDKGENYCFSVQAVIPSRTVNRKSTDSP -> YSTSLELW FT YLWSSSLSSSWLYLYTSVERQEWGRAGRRTPH (in isoform 2)" FT /evidence="ECO:0000303|PubMed:12652293" FT /id="VSP_041896" FT VAR_SEQ 239..295 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:12652293" FT /id="VSP_041897" FT VARIANT 36 FT /note="T -> A (in dbSNP:rs3917604)" FT /evidence="ECO:0000269|Ref.9" FT /id="VAR_014298" FT VARIANT 145 FT /note="I -> V (in dbSNP:rs3917627)" FT /evidence="ECO:0000269|Ref.9" FT /id="VAR_014299" FT VARIANT 163 FT /note="R -> W (in dbSNP:rs5901)" FT /id="VAR_012008" FT VARIANT 281 FT /note="G -> E (in dbSNP:rs3789683)" FT /id="VAR_052280" FT CONFLICT 260 FT /note="V -> A (in Ref. 1; AAA61151)" FT /evidence="ECO:0000305" FT STRAND 42..49 FT /evidence="ECO:0007829|PDB:6R2W" FT STRAND 52..58 FT /evidence="ECO:0007829|PDB:6R2W" FT STRAND 62..72 FT /evidence="ECO:0007829|PDB:6R2W" FT STRAND 73..75 FT /evidence="ECO:0007829|PDB:1UJ3" FT STRAND 78..85 FT /evidence="ECO:0007829|PDB:6R2W" FT STRAND 87..90 FT /evidence="ECO:0007829|PDB:6R2W" FT HELIX 92..95 FT /evidence="ECO:0007829|PDB:6R2W" FT HELIX 96..98 FT /evidence="ECO:0007829|PDB:2HFT" FT STRAND 103..111 FT /evidence="ECO:0007829|PDB:6R2W" FT HELIX 113..115 FT /evidence="ECO:0007829|PDB:1Z6J" FT TURN 119..122 FT /evidence="ECO:0007829|PDB:4YLQ" FT STRAND 126..128 FT /evidence="ECO:0007829|PDB:6R2W" FT HELIX 134..137 FT /evidence="ECO:0007829|PDB:6R2W" FT STRAND 145..151 FT /evidence="ECO:0007829|PDB:6R2W" FT STRAND 154..159 FT /evidence="ECO:0007829|PDB:6R2W" FT STRAND 163..168 FT /evidence="ECO:0007829|PDB:6R2W" FT STRAND 171..174 FT /evidence="ECO:0007829|PDB:6R2W" FT HELIX 175..179 FT /evidence="ECO:0007829|PDB:6R2W" FT HELIX 180..182 FT /evidence="ECO:0007829|PDB:6R2W" FT STRAND 184..191 FT /evidence="ECO:0007829|PDB:6R2W" FT STRAND 194..196 FT /evidence="ECO:0007829|PDB:3TH2" FT STRAND 198..210 FT /evidence="ECO:0007829|PDB:6R2W" FT STRAND 213..215 FT /evidence="ECO:0007829|PDB:1WV7" FT STRAND 217..224 FT /evidence="ECO:0007829|PDB:6R2W" FT STRAND 229..231 FT /evidence="ECO:0007829|PDB:6R2W" FT STRAND 240..243 FT /evidence="ECO:0007829|PDB:1BOY" FT STRAND 279..284 FT /evidence="ECO:0007829|PDB:2CEF" FT STRAND 289..293 FT /evidence="ECO:0007829|PDB:2CEF" SQ SEQUENCE 295 AA; 33068 MW; D3486C713ED8EAD0 CRC64; METPAWPRVP RPETAVARTL LLGWVFAQVA GASGTTNTVA AYNLTWKSTN FKTILEWEPK PVNQVYTVQI STKSGDWKSK CFYTTDTECD LTDEIVKDVK QTYLARVFSY PAGNVESTGS AGEPLYENSP EFTPYLETNL GQPTIQSFEQ VGTKVNVTVE DERTLVRRNN TFLSLRDVFG KDLIYTLYYW KSSSSGKKTA KTNTNEFLID VDKGENYCFS VQAVIPSRTV NRKSTDSPVE CMGQEKGEFR EIFYIIGAVV FVVIILVIIL AISLHKCRKA GVGQSWKENS PLNVS //